1. Bünzli J. C. G. Benefiting from the unique properties of lanthanide ions. Acc. Chem. Res., 2006, 39 (1), 53–61. DOI:https://doi.org/10.1021/ar0400894

2. David T., Šedinová M., Myšková A. Ultra-inert lanthanide chelates as mass tags for multiplexed bioanalysis. Nat. Commun., 2024, 15, 9836. DOI:https://doi.org/10.1038/s41467-024-53867-1

3. Zhang Q., O'Brien S., Grimm J. Biomedical applications of lanthanide nanomaterials, for imaging, sensing and therapy. Nanotheranostics, 2022, 6(2), 184. DOI:https://doi.org/10.7150/ntno.65530

4. Butranova O. I., Zyryanov S. K. The use of gabapentin for the therapy of neuropathic pain: a view from the standpoint of evidence-based medicine. Pharmacy and Pharmacology, 2024, (1), 74-88. Available at: https://cyberleninka.ru/article/n/primenenie-gabapentina-dlya-terapii-neyropaticheskoy-boli-vzglyad-s-pozitsiy-dokazatelnoy-meditsiny (accessed: 26.03.2026) DOI: https://doi.org/10.19163/2307-9266-2024-12-1-74-88

5. Frolova V. I., Gushanskaya E. V., Medvedev V. E. Adjuvant therapy of depressions with the drug gabapentin. STPN, 2023, (3–4), 27-34. Available at: https://cyberleninka.ru/article/n/adyuvantnaya-terapiya-depressiy-preparatom-gabapentin (accessed: 26.03.2026)

6. Swetha G. A., Sachin H. P., Choudhuri J. R. Performance of an anticonvulsant drug, expired gabapentin, on zinc corrosion in an acidic environment. Emerg. Mat., 2023, 6 (2), 721–740. DOI:https://doi.org/10.1007/s42247-023-00481-4

7. Manna D., Ghanty T. K. Complexation behavior of trivalent actinides and lanthanides with 1,10 phenanthroline-2,9-dicarboxylic acid based ligands: insight from density functional theory. Phys. Chem. Chem. Phys., 2012, 14 (31), 11060–11069. DOI:https://doi.org/10.1039/C2CP40083A

8. Cherkasova E. V. Structural characteristics of (N-thiocyanato) chromates (III) of lanthanides (III) with pyridine-3-carboxylic acid. Russ. J. of Coord. Chem., 2025, 51 (7), 579–585. DOI:https://doi.org/10.1134/S1070328425600366

9. Gourdon L., Cariou K., Gasser G. Phototherapeutic anticancer strategies with first-row transition metal complexes: a critical review. Chem. Soc. Rev., 2022, 51 (3), 1167–1195. DOI:https://doi.org/10.1039/D1CS00609F

10. Lugones Y., Loren P., Salazar L. A. Cisplatin resistance: genetic and epigenetic factors involved. Biomolecules, 2022, 12 (10), 1365. DOI:https://doi.org/10.3390/biom12101365

11. Zhang Y. DNA binding studies and in-vitro anticancer studies of novel lanthanide complexes. Int. J. Biol. Macromol., 2024, 279, 135048. DOI:https://doi.org/10.1016/j.ijbiomac.2024.135048

12. Galaup C. Luminescent lanthanide complexes for reactive oxygen species biosensing and possible application in Alzheimer’s diseases. FEBS J., 2022, 289 (9), 2516–2539. DOI:https://doi.org/10.1111/febs.15859

13. Akitsu T. Lanthanide complexes in recent molecules. Molecules, 2022, 27 (18), 6019. DOI:https://doi.org/10.3390/molecules27186019

14. Hassan S. S. M., Mahmoud W. H. Spectrophotometric, potentiometric, and gravimetric determination of lanthanides with peri-dihydroxynaphthindenone. Anal. Chem., 1982, 54 (2), 228–231. DOI:https://doi.org/10.1021/ac00239a019

15. Blagojević D. Determination of chloride content in bottled mineral water. Acta Sci. Balcanica, 2022, 3 (1). DOI:https://doi.org/10.7251/ASB220301003B

16. OFS.1.2.1.0005.15 Solubility. State Pharmacopoeia of the Russian Federation [Electronic resource]. Available at: https://pharmacopoeia.regmed.ru/ (accessed: 26.03.2026)

17. Bockbrader H. N., Wesche D., Miller R., Chapel S., Janiczek N., Burger P. A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin. pharmacokinet., 2010, 49(10), 661-669. DOI:https://doi.org/10.2165/11536200-000000000-00000